The core activity of TPS-Neurowave is the treatment of dementia, particularly Alzheimer's disease, using Transcranial Pulse Stimulation (TPS). The company offers a non-pharmacological treatment method based on the application of gentle shock waves (ultrasound pulses).
AI-generated
Offering
Products & services
Industry:Neurology Clinics
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Transcranial pulse stimulation with short sound pulses for outpatient treatment of dementia, Long-Covid, ADHD and depression; painless, non-medication-based, with initial treatment and maintenance therapy.
Outpatient treatment series
Initial treatment with six sessions, each 30–40 minutes, within two to three weeks; followed by recommended individual sessions for maintenance therapy at six- to eight-week intervals.
Neurological assessment and additional examinations
Separate neurological and cognitive examination in the first session, as well as specific examinations and neurological tests, if no pre-existing records are available.
Knowledge
No knowledge articles yet
Once TPS Neurowave AG has claimed this profile, we'll publish editorial articles and case studies here together.